Life Sciences

Frost & Sullivan's expertise in Life Sciences research and consulting includes work in diversified strategic and operational areas

The life sciences industry is undergoing rapid change, dynamic discoveries and pressures driving business decisions and corporate growth. Business models are being forced to evolve as healthcare continues to shift from a treatment focus to points of wellness, prediction, personalization, and prevention.

Recognizing the interdependence of the payer, provider and pharmaceutical value chains, companies are re-inventing strategies in multitude ways: increased outsourcing, co-development and patient engagement are the new norms.

The Frost & Sullivan Global Life Sciences Program helps you better understand stakeholder dynamics as the healthcare system transitions from acute care into integrated care. Our research and insights help you make informed strategic decisions around how best to navigate this complex market.

We can support needs from syndicated research to projects ranging from proprietary strategic engagements and market research, marketing solutions, and whitepapers, all leveraging the global reach of our firm to propel your business forward.

We believe a structured partnership that provides you transformational insights through online content as well as deeper interaction with our senior analyst team will help ensure greater relevancy of insights provided for your organization.

  1. 03 Aug 2015  |  Africa  |  Market Research

    China Contract Research Organisation Market

    Exploring the Market Landscape and Future Opportunities

    The pharmaceutical industry in Ghana and Nigeria is forecast to represent a combined business opportunity of over $3 billion by 2018, propelled by a convergence of changing economic profiles, increased healthcare spending and investment, and increasing incidence of chronic diseases. Market segmentation is done based on products (OTC, generic, and b...

    $1,500.00
  2. 03 Aug 2015  |  Europe  |  Market Research

    The South Korean Contract Research Organization Market

    Government Initiatives Offer Powerful Boost to the Clinical Trials Industry

    Vaccines represent a class of biologics that are administered to prevent infectious diseases to reduce mortality and morbidity. It is estimated that the introduction of vaccines has reduced the incidence of various diseases by greater than 90%. This study examines the global vaccines market, including marketed products and products under clinical d...

    $1,500.00
  3. 07 Aug 2015  |  Asia Pacific  |  Market Research

    Japan Contract Research Organization Market

    Aging Population and Liberal Regulations will Propel Clinical Trial Growth

    This research service presents an overview and analysis of the contract research organization (CRO) market. It provides revenue forecasts for the CRO market by phase and therapeutic type. The study discusses the key challenges, unmet needs, and emerging trends in the market and. It covers the complete life cycle of the CRO industry, starting from p...

    $1,500.00
  4. 07 Aug 2015  |  Global  |  Market Research

    Indian Contract Research Organization (CRO) Market

    The Evolving Regulatory Scenario is Likely to Boost Market Growth

    This study assesses marketed and in-research products and combination regimens for the lung cancer therapeutics market. Segmentation by drug class is provided, along with additional supporting information such as clinical trial timelines and results, historical and projected launch timelines, and epidemiology. The marketed and pipeline products are...

    $1,500.00
  5. 12 Aug 2015  |  Global  |  Market Research

    Singapore Contract Research Organization Market

    Singapore will Remain in the Global Spotlight as the Strategic Hub of the CRO Market in APAC.

    The research service assesses marketed and investigational products, as well as combination regimens, for asthma and chronic obstructive pulmonary disease (COPD). Segmentation by drug class is provided along with additional supporting information such as clinical trial timelines and results, historical and projected launch timelines, and epidemiolo...

    $1,500.00
  6. 14 Aug 2015  |  North America  |  Market Research

    The Australian Contract Research Organization Market

    Early Phase Clinical Trials are Set to Drive the Australian CRO Market

    Drug-resistant bacteria, or superbugs, pose a serious threat to human health. Developing new antibacterial drugs requires a great deal of time, effort, expenditure, and scientific research, making it a less-attractive segment for investment by pharmaceutical companies. This research service focuses on the global antibacterial drugs (antibiotics) ma...

    $1,500.00
  7. 19 Aug 2015  |  North America  |  Market Research

    Top 6 Trends Affecting the Diagnostics Market

    Evolving Strategies by Market Leaders to Keep Up With Changing Healthcare Trends

    The IVD market constantly changing. Mega Trends such as consolidation, automation, and reimbursement policies affect every aspect of the market. This study looks at the effects of these trends on three global consumer segments: hospitals, laboratories, and patients. The growing importance of diagnostics in patient care is expanding beyond hospitals...

    $1,500.00
  8. 02 Sep 2015  |  Global  |  Market Research

    The New Age of Regenerative Medicine

    Why Stem Cell Therapy?

    Cell therapy is the fastest growing segment of the Regenerative Medicine (RM) industry. It comprises both immune cell therapy and stem cell therapy; however, stem cell therapy makes up the largest part of this segment. The global cell therapy market is driven by the success of stem cell treatments in treating or curing life-threatening diseases suc...

    $1,500.00
  9. 02 Sep 2015  |  Asia Pacific  |  Market Research

    Analysis of the Global Human Albumin Market and Product Pipeline

    Emerging Economies and Use of Human Albumin as an Excipient Present New Growth Opportunities

    The infectious disease IVD market in Indonesian presents diversified growth potential for different tiers of participants. Domestic participants stand to gain from the growth momentum in the lower-end market, whereas foreign leading manufacturers dominate the higher-end market. This research service analyses the infectious disease IVD market and p...

    $4,950.00
  10. 03 Sep 2015  |  Asia Pacific  |  Market Research

    Impact of Policies Shaping ASEAN Healthcare—Outlook till 2020

    Policies Raising Standards and Lowering Barriers Across ASEAN

    The research service provides an analysis of the policies impacting the healthcare market in the Association of Southeast Asian Nations (ASEAN). It includes the current trends, market size, revenue forecast, and market drivers and restraints. Healthcare market participants and key opinion leaders were interviewed to obtain their perception about tr...

    $2,450.00